Literature DB >> 8769475

A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation.

F Ossendorp1, M Eggers, A Neisig, T Ruppert, M Groettrup, A Sijts, E Mengedë, P M Kloetzel, J Neefjes, U Koszinowski, C Melief.   

Abstract

CTL epitope (KSPWFTTL) encoded by AKV/MCF type of murine leukemia virus (MuLV) differs from the sequence in Friend/Moloney/Rauscher (FMR) type in one residue (RSPWFTTL). CTL experiments indicated defective processing of the FMR peptide in tumor cells. Proteasome-mediated digestion of AKV/MCF-type 26-mer peptides resulted in the early generation and higher levels of epitope-containing fragments than digestion of FMR-type peptides, explained by prominent cleavage next to R in the FMR sequence. The fragments were identified as 10- and 11-mer peptides and were efficiently translocated by TAP. The naturally presented AKV/MCF peptide is the 8-mer, indicating ER peptide trimming. In conclusion, a single residue exchange can cause CTL epitope destruction by specific proteasomal cleavage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769475     DOI: 10.1016/s1074-7613(00)80488-4

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  44 in total

1.  A kinetic model of vertebrate 20S proteasome accounting for the generation of major proteolytic fragments from oligomeric peptide substrates.

Authors:  H G Holzhütter; P M Kloetzel
Journal:  Biophys J       Date:  2000-09       Impact factor: 4.033

2.  Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells.

Authors:  A Samri; G Haas; J Duntze; J M Bouley; V Calvez; C Katlama; B Autran
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome.

Authors:  Can Kesmir; Vera van Noort; Rob J de Boer; Paulien Hogeweg
Journal:  Immunogenetics       Date:  2003-08-30       Impact factor: 2.846

4.  Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells.

Authors:  O O Yang; A C Tran; S A Kalams; R P Johnson; M R Roberts; B D Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

5.  Virus-induced diabetes in a transgenic model: role of cross-reacting viruses and quantitation of effector T cells needed to cause disease.

Authors:  N Sevilla; D Homann; M von Herrath; F Rodriguez; S Harkins; J L Whitton; M B Oldstone
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.

Authors:  Stefan Tenzer; Edmund Wee; Anne Burgevin; Guillaume Stewart-Jones; Lone Friis; Kasper Lamberth; Chih-hao Chang; Mikkel Harndahl; Mirjana Weimershaus; Jan Gerstoft; Nadja Akkad; Paul Klenerman; Lars Fugger; E Yvonne Jones; Andrew J McMichael; Søren Buus; Hansjörg Schild; Peter van Endert; Astrid K N Iversen
Journal:  Nat Immunol       Date:  2009-05-03       Impact factor: 25.606

7.  Computational prediction of cleavage using proteasomal in vitro digestion and MHC I ligand data.

Authors:  Yu-feng Lu; Hao Sheng; Yi Zhang; Zhi-yang Li
Journal:  J Zhejiang Univ Sci B       Date:  2013-09       Impact factor: 3.066

8.  Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1.

Authors:  A K Nussbaum; T P Dick; W Keilholz; M Schirle; S Stevanović; K Dietz; W Heinemeyer; M Groll; D H Wolf; R Huber; H G Rammensee; H Schild
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

Review 9.  Antigen processing by proteasomes: insights into the molecular basis of crypticity.

Authors:  H Djaballah
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

10.  Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice.

Authors:  A Geluk; V Taneja; K E van Meijgaarden; E Zanelli; C Abou-Zeid; J E Thole; R R de Vries; C S David; T H Ottenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.